ShareValue scores for ALMDT.PA: Valuation 50, Quality 34, Growth 53, Health 49.

Mediantechn logo

ALMDT.PA
Euronext Paris

Mediantechn

€4.09(-0.85%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
50
Fair Value
Price vs Value
Quality
34
Weak
Business Strength
Growth
53
Moderate
Revenue & Earnings
Health
49
Moderate
Financial Stability
Momentum
57
Neutral
Price Trend

Company Details

About

Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iCRO, an imaging service for oncology clinical trials; and eyonis, an end-to-end CADe/CADx software as medical devices. The company was founded in 2002 and is based in Valbonne, France.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026